Compare MKSI & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKSI | FMS |
|---|---|---|
| Founded | 1961 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 14.2B |
| IPO Year | 1997 | N/A |
| Metric | MKSI | FMS |
|---|---|---|
| Price | $213.79 | $22.71 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 13 | 2 |
| Target Price | ★ $256.00 | $30.00 |
| AVG Volume (30 Days) | ★ 1.3M | 572.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.47% | ★ 2.51% |
| EPS Growth | ★ 55.52 | N/A |
| EPS | ★ 4.37 | N/A |
| Revenue | ★ $3,931,000,000.00 | N/A |
| Revenue This Year | $15.64 | $1.41 |
| Revenue Next Year | $10.58 | $4.11 |
| P/E Ratio | $48.88 | ★ $15.62 |
| Revenue Growth | ★ 9.62 | N/A |
| 52 Week Low | $54.84 | $20.96 |
| 52 Week High | $269.91 | $30.46 |
| Indicator | MKSI | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 42.71 |
| Support Level | $212.91 | $22.50 |
| Resistance Level | $246.35 | $24.08 |
| Average True Range (ATR) | 10.73 | 0.40 |
| MACD | -4.82 | -0.10 |
| Stochastic Oscillator | 16.23 | 30.25 |
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.